Archives
FDA Panel Says Yes to Pfizer Booster Shots for People 65+
Same independent panel of experts said no to booster shots for Americans younger than 65 years
Americans Struggling With High Cost of Prescription Drugs
Adults younger than 65 years twice as likely to report not filling needed prescriptions due to cost versus seniors
Delta Variant Now Fueling 99 Percent of U.S. COVID-19 Cases
The delta variant is driving the increase in hospitalizations
Review of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: Fauci
Fauci says data on booster shots for those vaccines are only a few weeks away from a review by the FDA
Physician’s Briefing Weekly Coronavirus Roundup
Pfizer Recalls All Lots of Chantix Due to Potential Carcinogen
0.5-mg and 1-mg tablets may contain levels of N-nitroso-varenicline at or above levels approved by the FDA
FDA Advisory Panel to Hold Meeting Today on COVID-19 Booster Shots
Advisory panel will review a variety of evidence, including new data from Israel
Vaccines’ Power Against COVID-19 Hospitalization Fades in Elderly
Hospitalization rates among fully vaccinated higher among older residents of nursing homes and among those with underlying conditions
Toxic Leaded Gasoline Is Finished Globally
Use of the fuel has been linked to a wide range of human health problems
Prescriptions Rise for Veterinary Drug for COVID-19 Patients
Increase in demand for ivermectin has been accompanied by a fivefold increase in calls to poison control centers
